Crispr Therapeutics shares owned by Whipplewood Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Whipplewood Advisors
from 13F filings
Historical chart of Whipplewood Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Whipplewood Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Whipplewood Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $178k | 3.4k | 52.44 |
| 2025-09-30 | $220k | 3.4k | 64.81 |
| 2025-06-30 | $201k | 4.1k | 48.64 |
| 2025-03-31 | $137k | 5 | 27475.80 |